Form 4: Aspira Women's Health Director Exercises Stock Options
SEC Form 4 Filing
Director John Phillip Ragard converted 4,844 restricted stock units into common stock of Aspira Women's Health Inc. on September 30, 2024.
Summary
- On September 30, 2024, John Phillip Ragard, a director of Aspira Women's Health Inc., converted 4,844 restricted stock units (RSUs) into common stock.
- This transaction was reported on a Form 4 filed with the SEC on October 2, 2024.
- Following the transaction, Ragard directly owns 120,203 shares of Aspira Women's Health Inc. common stock and 14,531 restricted stock units.
- The RSUs were granted on August 22, 2024, with a portion vesting on September 30, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 19,375 RSUs. |
| 08/26/2024 | Previous Form 4 filed with the SEC reporting the RSU grant. |
| 09/30/2024 | 4,844 RSUs vested and were converted into common stock. |
| 10/02/2024 | Date of Form 4 filing. |
Keywords
Aspira Women's Health, Director, Stock Options, RSUs, Form 4, Ragard, Common Stock, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.